{"url_path":"/sec/vsee/8-k/2026-06-05/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 ****Departure","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-05","source_url":"https://www.sec.gov/Archives/edgar/data/1864531/0001185185-26-002359-index.html","accession_number":"0001185185-26-002359","cik":"0001864531","ticker":"VSEE","issuer_name":"VSEE HEALTH, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1864531/0001185185-26-002359-index.html","primary_entity_key":"0001864531","primary_entity_name":"VSEE HEALTH, INC."},"word_count":102,"has_tables":true,"body_markdown":"** **\n\n**Item\n5.02****Departure\nof Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;\nCompensatory Arrangements of Certain Officers.**\n\n \n\nThe\ninformation set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference into this Item 5.02.\n\n \n\nMr. Chen’s resignation was not because of any\ndisagreement between Mr. Chen and the Company on any matter relating to the Company’s operations, policies or practices. Concurrently\nwith Mr. Chen’s resignation, Dr. Imoigele Aisiku, the Company’s co-Chief Executive Officer, was appointed as the sole Chief\nExecutive Officer and the chairman of the board of directors of the Company, effective immediately."}